CT, Y., JJ, L., PJ, C., WL, H., DC, C., YH, L., . . . X, C. (2026). Paradoxical myocardial infarction risk with dual antiplatelet therapy in East Asian ischaemic stroke: A nationwide real-world cohort study and pharmacogenomic risk prediction model. Therapeutic advances in neurological disorders, 19, 17562864261456919. https://doi.org/10.1177/17562864261456919
Chicago Style (17th ed.) CitationCT, Yang, et al. "Paradoxical Myocardial Infarction Risk with Dual Antiplatelet Therapy in East Asian Ischaemic Stroke: A Nationwide Real-world Cohort Study and Pharmacogenomic Risk Prediction Model." Therapeutic Advances in Neurological Disorders 19 (2026): 17562864261456919. https://doi.org/10.1177/17562864261456919.
MLA (9th ed.) CitationCT, Yang, et al. "Paradoxical Myocardial Infarction Risk with Dual Antiplatelet Therapy in East Asian Ischaemic Stroke: A Nationwide Real-world Cohort Study and Pharmacogenomic Risk Prediction Model." Therapeutic Advances in Neurological Disorders, vol. 19, 2026, p. 17562864261456919, https://doi.org/10.1177/17562864261456919.